Further examination of the effects of HDAC inhibitors with imatinib on primitive LSCs resulted in increased apoptosis of the CML progenitors (Zhang et al., 2010). The gene discussed is HDAC9; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.